Trial Highlights

Elamipretide is an investigational drug with the potential to modify disease through its apparent ability to restore normal energy production in damaged mitochondria, while decreasing oxidative stress.8 This clinical candidate is being developed for both rare and commmon diseases, representing a novel therapeutic approach with the potential to treat a wide variety of unmet patient needs.

Our systemic clinical programs highlight several therapeutic areas, including cardiorenal indications and rare mitochondrial diseases. By defining the broad potential of its mitochondrial platform and therapies, we are leading mitochondrial medicine.

Systemic Formulation of Elamipretide in Clinical Studies

Rare Diseases


Observational Study


Cardiorenal Diseases


Completed Clinical Trials

Elamipretide in Clinical Trials

For more information, visit www.clinicaltrials.gov and search ‘Stealth BioTherapeutics’.